POPetteri Oura

Petteri Oura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Petteri Oura has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Juho-Antti Junno

    Department of Archaeology, University of Oulu, P.O. Box 8000, FI-90014, Oulu, Finland; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, P.O. Box 8000, FI-90014, Oulu, Finland; Archaeology, University of Helsinki, P.O. Box 4, FI-00014, Helsinki, Finland

    7 shared publications
  • Antti Sajantila

    Department of Forensic Medicine , Faculty of Medicine FI-00014, Helsinki , Finland

    4 shared publications
  • Alina Junno

    Department of Archaeology, University of Oulu, P.O. Box 8000, FI-90014, Oulu, Finland

    3 shared publications
  • Antti J. Hakkarainen

    Department of Forensic Medicine, University of Helsinki, P.O. Box 21, Helsinki FI-00014, Finland; Forensic Medicine Unit, Finnish Institute for Health and Welfare, P.O. Box 30, Helsinki FI-00271, Finland

    3 shared publications
  • Essi Laakko

    Department of Forensic Medicine, University of Helsinki, P.O. Box 21, FI-00014, Helsinki, Finland

    3 shared publications
  • Hilla Mäkinen

    Forensic Medicine Unit, Finnish Institute for Health and Welfare, P.O. Box 30, Helsinki FI-00271, Finland

    3 shared publications

Latest Publications

  • Open Access

    β-amyloid precursor protein immunoreactivity in fatal polysubstance poisonings: a neuropathologically examined autopsy case series

    by Totti Kivelä, Paula Katriina Vauhkonen, Roosa Koskela, Pirkko Kriikku, Petteri Oura

    It is not always possible to definitively establish fatal poisoning by means of postmortem toxicology alone. Beta-amyloid precursor protein (β-APP) immunoreactivity has been reported in substance poisoning deaths in various regions of the brain, opioids being of particular interest in this matter. We aimed to report β-APP immunoreactivity in polysubstance poisoning deaths, most of them buprenorphine-driven, and discuss the potential uses of β-APP in suspected fatal poisonings. We analysed a series of 14 neuropathologically examined medico-legal autopsy cases that had undergone toxicological analysis and systematic sampling of the brain for β-APP at the Finnish Institute for Health and Welfare. The cases comprised poisonings with vascular axonal injury (VAI) in β-APP ( n = 7), poisonings without VAI in β-APP ( n = 3), and controls ( n = 4). All ten poisonings involved multiple substances. Eight were opioid-driven; other central nervous system (CNS) depressants and stimulants were also detected. β-APP immunoreactivity indicative of VAI was observed in seven cases; most common sites were the corpus callosum ( n = 7), pons ( n = 7), and internal capsule ( n = 6). In conclusion, β-APP immunoreactivity was present in most poisoning deaths caused by CNS depressants. They may cause delayed death through respiratory depression, expediting the development of VAI that can be detected via β-APP. In such deaths, a good example being buprenorphine-driven ones, postmortem blood concentrations may not suffice to definitively establish poisoning.

  • Open Access

    Neuropathological diagnoses and age-related differences in Finnish medico-legal autopsies of individuals aged 65 years and older

    by Emma Pellikka, Paula K. Vauhkonen, Petteri Oura

    As populations worldwide continue to grow older, an increase in cases involving aged individuals is also to be expected in medico-legal autopsies. The aim of this study was to report the neuropathological diagnoses of individuals aged ≥ 65 years, and to compare the findings across three age groups: youngest-olds (65–74 years of age), middle-olds (75–84) and oldest-olds (≥ 85). The sample comprised all Finnish medico-legal autopsies of individuals aged ≥ 65 years whose autopsy included a full neuropathological examination performed by a neuropathologist over the period 2016–2022 ( n = 629). Neuropathological diagnoses were obtained from the neuropathologists’ reports, and background characteristics were collected from medico-legal cause-of-death investigation documents. Of all cases, 97.1% received at least one neuropathological diagnosis. The prevalences of many neurodegenerative diseases increased with age; Alzheimer’s disease neuropathological change (30.5%) and cerebral amyloid angiopathy (14.0%) were the most common ones. However, some rarer neurodegenerative diseases were more frequent among youngest-olds. While the prevalence of acute infarcts remained relatively consistent across the age groups (12.4–14.5%), old infarcts and subarachnoid haemorrhages were most common among oldest-olds (22.1% and 16.6%, respectively). The age-related increase in subarachnoid haemorrhage diagnoses appeared to be primarily driven by the male sex. The prevalences of acute and old traumatic brain injuries were rather low (5.7–6.2% and 5.1%, respectively) and remained relatively stable across the age groups. In conclusion, our data suggest that neuropathological diagnoses are highly prevalent among aged individuals undergoing medico-legal autopsy, and many diagnoses become more frequent towards oldest-olds.


  • Open Access

    Prevalence of epilepsy and seizure history in Finnish neuropathologically examined medico-legal autopsy cases with acute head injuries

    by Gaia Narayan, Petteri Oura

    Objectives: Epilepsy and traumatic brain injury have a bidirectional relationship. This study aimed to report the prevalences of antemortem epilepsy diagnosis, seizure history, epilepsy-related and traumatic neuropathological findings, as well as background characteristics, among neuropathologically examined medico-legal autopsy cases with acute head injuries. Results: The sample included 82 cases from Helsinki, Finland, from the years 2016—2022. Of the sample, 17 cases had an epilepsy diagnosis or documented seizure history (“Epilepsy/Seizure Group”), whereas 65 did not (“No Seizure Group”). The most frequent epilepsy-related neuropathological findings were hippocampal atrophy and mossy fibre sprouting. Of background characteristics, the Epilepsy/Seizure Group had a higher prevalence of old head injuries (41.2% vs. 7.7%) and chronic alcohol use (41.2% vs. 18.5%) than the No Seizure Group. There were no statistically significant differences in acute head injuries or secondary neuropathological findings, except for a lower prevalence of oedema in the Epilepsy/Seizure Group (17.6% vs. 47.7%). Even though the Epilepsy/Seizure Group had a higher prevalence of old head injuries and chronic alcohol use, the prevalences of acute head injuries were not higher. Larger studies are needed to further explore whether individuals with epilepsy or seizure history are susceptible to distinct head injury types or circumstances.

  • Open Access

    Neuropathologic findings and age‐related differences in Finnish pediatric medico‐legal autopsies

    by Elias Hakanen, Petteri Oura, Paula Katriina Vauhkonen

    Neuropathological examination plays a critical role in medico‐legal cause‐of‐death investigation, especially in determining the cause and manner of death in pediatric autopsies. Although a comprehensive neuropathological examination is recommended, limited data exists of the diagnostic yield of neuropathology consultations in such cases. This retrospective register‐based study reviewed Finnish pediatric medico‐legal autopsies from 2016 to 2022 involving full neuropathological examination performed by a neuropathologist, with a focus on age‐related differences in consultation rates, themes, and diagnostic findings. Data were retrieved from the medico‐legal cause‐of‐death investigation documents, and included background characteristics, neuropathologic diagnoses, and causes and manners of death. A total of 118 pediatric medico‐legal autopsies with a neuropathology consultation were performed during the study period. The consultation rate was highest among infants (aged <1 year; 45.6%), compared to early childhood (aged 1–10 years; 23.0%) and late childhood (aged 11–18 years; 6.2%). Traumatic brain injury was the most frequent consultation theme overall (33.9%), while the frequency of epilepsy‐related consultations increased with age. Hypoxic‐ischaemic neuronal injury constituted the commonest finding, with an overall prevalence of 43.2%. Findings associated with childhood epilepsy were more prevalent in early and late childhood, with epilepsy accounting for 15.2% of deaths in the latter group. Positive diagnostic findings were uncommon among infants, consistent with a high proportion of cases (42.1%) classified as sudden infant death syndrome. These findings provide forensic pathologists with age‐specific diagnostic insights, supporting more targeted resource use and neuropathology consultation practices.


  • Open Access

    Identifying patterns of neuropathological diagnoses in medico-legal autopsies – A latent class analysis of 1270 neuropathologically examined cases from Finland

    by Xiaojian Keinänen, Paula K. Vauhkonen, Petteri Oura

    Neuropathological diseases and injuries are common causes of death and frequently encountered in medico-legal autopsies. Previous studies have suggested that many neuropathological findings co-occur. This retrospective and register-based study aimed to identify latent subgroups of neuropathological diagnoses, including both disease and injury findings. The sample comprised 1270 neuropathologically examined medico-legal autopsy cases from the Forensic Medicine Unit of the Finnish Institute for Health and Welfare over the years 2016–2022. Neuropathological diagnoses were obtained from neuropathologists’ reports, and background characteristics were collected from medico-legal cause-of-death investigation documents. Latent class analysis (LCA) was applied to identify clustering of neuropathological diagnoses among the sample. The dataset comprised 60.6% males, and the median age at death was 64 (interquartile range 43–77) years. LCA models with 2–8 classes were explored; the 3-class model was considered best fit, based on Bayesian Information Criterion values and interpretability. Class 1 was characterized by high prevalences of neurodegenerative and degenerative cerebrovascular diseases, as well as highest age. Class 2 included most cases with acute haemorrhages, their potential causes, and secondary complications. Class 3 comprised a diverse range of neuropathological diagnoses, including cases with epilepsy-related consultation questions and diagnoses. Awareness of co-occurring neuropathological diagnoses would be expected to advocate diagnostic vigilance and facilitate contextual interpretation of co-existing findings in the medico-legal practice. Having demonstrated the feasibility and potential relevance of LCA in forensic neuropathology, this study encourages future applications of LCA in other medico-legal contexts.


  • Open Access

    Comparison of background characteristics and neuropathology findings between medico-legal autopsy cases with traumatic axonal injury, vascular axonal injury, or absence of axonal injury in β-amyloid precursor protein stain

    by Gaia Narayan, Petteri Oura

    In forensic neuropathology, the β-amyloid precursor protein (β-APP) immunostain is used to diagnose axonal injury (AI). The two most common aetiologies are traumatic (TAI) and ischaemic (vascular; VAI). We aimed to identify background characteristics and neuropathology findings that are suggestive of TAI, VAI, or no AI in neuropathologically examined medico-legal autopsy cases. The dataset comprised 166 cases from Finland over the period 2016—2023. The diagnosis of AI was based on β-APP stain (TAI, VAI, or no AI). Data on background characteristics and neuropathology findings were collected from cause-of-death investigation documents. Prevalence ratios were calculated for each variable to enable comparisons between the AI categories. The sample were 71.7% males; median age was 41 years (range 0—96). There were 26 cases with TAI, 44 with VAI, and 96 with no AI. The variables that showed statistical significance and had at least two-fold prevalence among TAI cases compared to VAI cases were: a documented recent injury; and presence of any extracranial/cranial/intracranial injury (including subdural haemorrhage [SDH], subarachnoid haemorrhage [SAH], intracerebral/ventricular haemorrhage [ICVH], or contusion) in autopsy or neuropathology. Correspondingly, variables indicating TAI over no AI were: a documented recent injury; postinjury survival ≥ 24 h; and presence of any extracranial/cranial/intracranial injury (including SDH, SAH, ICVH, contusion), herniation, or infarction in autopsy or neuropathology. Postinjury survival < 30 min was identified as an indicator of no AI over TAI. Finally, variables indicating VAI over no AI were: postinjury survival ≥ 24 h; lack of external injury to the head; and presence of SDH, brain oedema, herniation, or infarction in autopsy or neuropathology. In conclusion, we report several differences in characteristics and findings between cases diagnosed with TAI, VAI, and no AI. Our findings may help estimate the likelihood and potential aetiology of AI based on background characteristics and other neuropathology findings.


  • Open Access

    First year of in-house forensic neuropathology consultations in Helsinki, Finland

    by Petteri Oura, Hilla Mäkinen, Roosa Ruotsalainen, Miko Ruokomäki, Antti Virtanen, Antti J. Hakkarainen

    In July 2023, an in-house forensic neuropathology consultation pilot was established at the Helsinki office of the Forensic Medicine Unit, Finnish Institute for Health and Welfare. This offered an alternative to the previous practice of full outsourcing to a hospital neuropathology department. This paper aims to introduce the first year experiences of the pilot. The in-house consultant team comprised two forensic pathologists with special training in neuropathology. In-house consultations were offered for medico-legal autopsy cases with traumatic brain injury (TBI) and hypoxic-ischaemic encephalopathy. The in-house histology laboratory participated in the pilot, implementing beta-amyloid precursor protein (β-APP) stain at the end of the pilot year. An electronic database was also developed for data collection and reporting. The characteristics, costs, and duration of the first 25 consultation cases were reviewed. The cases involved mostly male decedents (84.0%) with TBI (84.0%). The median total cost of a pilot case was €624, which was substantially lower compared to the previous outsourced practice (€1013 per case + €38/84 for each microscope slide with special/immunohistochemical stain, respectively). After the implementation of β-APP stain into the in-house laboratory service, the median total cost of a pilot case was reduced further to €94. The median duration of an in-house consultation was 2.3 months. Thanks to a favourable in-house atmosphere, the first year experiences are encouraging. While the costs of the in-house consultation practice appear to be markedly lower than those of an external provider, both alternatives should be available for cases where sufficient expertise cannot be found in-house.